HEADER HYDROLASE/HYDROLASE INHIBITOR 25-NOV-98 1B11 TITLE STRUCTURE OF FELINE IMMUNODEFICIENCY VIRUS PROTEASE COMPLEXED WITH TL- TITLE 2 3-093 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (FELINE IMMUNODEFICIENCY VIRUS PROTEASE); COMPND 3 CHAIN: A; COMPND 4 EC: 3.4.23.16 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: FELINE IMMUNODEFICIENCY VIRUS; SOURCE 3 ORGANISM_TAXID: 11673 KEYWDS FIV PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.GUSTCHINA,M.LI,A.WLODAWER REVDAT 9 27-DEC-23 1B11 1 REMARK LINK REVDAT 8 13-JUL-11 1B11 1 VERSN REVDAT 7 08-DEC-09 1B11 1 HET HETATM HETNAM FORMUL REVDAT 7 2 1 REMARK REVDAT 6 28-APR-09 1B11 1 REMARK REVDAT 5 24-FEB-09 1B11 1 VERSN REVDAT 4 01-APR-03 1B11 1 JRNL REVDAT 3 01-FEB-02 1B11 1 JRNL REMARK HETNAM HETSYN REVDAT 2 22-DEC-99 1B11 1 HEADER CONECT REMARK JRNL REVDAT 2 2 1 ATOM SOURCE SEQRES REVDAT 1 02-DEC-98 1B11 0 JRNL AUTH M.LI,G.M.MORRIS,T.LEE,G.S.LACO,C.H.WONG,A.J.OLSON,J.H.ELDER, JRNL AUTH 2 A.WLODAWER,A.GUSTCHINA JRNL TITL STRUCTURAL STUDIES OF FIV AND HIV-1 PROTEASES COMPLEXED WITH JRNL TITL 2 AN EFFICIENT INHIBITOR OF FIV PROTEASE JRNL REF PROTEINS V. 38 29 2000 JRNL REFN ISSN 0887-3585 JRNL PMID 10651036 JRNL DOI 10.1002/(SICI)1097-0134(20000101)38:1<29::AID-PROT4>3.0.CO;2 JRNL DOI 2 -N REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.WLODAWER,A.GUSTCHINA,L.RESHETNIKOVA,J.LUBKOWSKI,A.ZDANOV, REMARK 1 AUTH 2 K.HUI,E.ANGLETON,W.FARMERIE,M.GOODENOW,D.BHATT,L.ZHANG, REMARK 1 AUTH 3 B.DUNN REMARK 1 TITL STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITH REMARK 1 TITL 2 AN EFFICIENT INHIBITOR OF FIV PR REMARK 1 REF NAT.STRUCT.BIOL. V. 2 480 1995 REMARK 1 REFN ISSN 1072-8368 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.9 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.179 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.176 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 10.500 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 903 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 8578 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.163 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.160 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 10.600 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 730 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 6856 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 900 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 43 REMARK 3 SOLVENT ATOMS : 60 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 1002.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 5 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 4117 REMARK 3 NUMBER OF RESTRAINTS : 3974 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 ANGLE DISTANCES (A) : 0.021 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.023 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.027 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.035 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.005 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.085 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 ANISOTROPIC SCALING APPLIED BY METHOD PF PARKIN, MOEZZI & HOPE, REMARK 3 J.APPL.CRYST.28(1995)53-56 REMARK 4 REMARK 4 1B11 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB. REMARK 100 THE DEPOSITION ID IS D_1000000154. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : SEP-97 REMARK 200 TEMPERATURE (KELVIN) : 297 REMARK 200 PH : 4.5-7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : ENRAF-NONIUS FR591 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAC SCIENCE DIP-2020 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9018 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08300 REMARK 200 FOR THE DATA SET : 9.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.69200 REMARK 200 FOR SHELL : 1.920 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SAMPLE: 3.4MG/ML FIVPR IN 25MM REMARK 280 IMIDAZOL BUFFER AT PH 7.0 WITH 1MM EDTA AND 10MM DTT. WELL REMARK 280 SOLUTION: 1.6M AMMONIUM SULFATE IN SODIUM ACETATE BUFFER AT PH REMARK 280 4.5 MIXING SAMPLE AND WELL SOLLUTION 1:1, PH 5.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 24.48600 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 48.97200 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 48.97200 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 24.48600 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10860 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -66.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 48.97200 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 301 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 13 NE - CZ - NH1 ANGL. DEV. = -3.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 46 -117.79 45.01 REMARK 500 ASN A 51 34.84 -141.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE INHIBITOR IS A C2 SYMMETRIC HIV PROTEASE REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: BENZYL [(1S,4S,7S,8R,9R,10S,13S,16S)-7,10-DIBENZYL- REMARK 630 8,9-DIHYDROXY-1,16-DIMETHYL-4,13-BIS(1-METHYLETHYL)-2,5,12,15,18- REMARK 630 PENTAOXO-20-PHENYL-19-OXA-3,6,11,14,17-PENTAAZAICOS-1-YL]CARBAMATE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 3TL A 201 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: PHQ ALA VAL PHL PHL VAL ALA PHQ REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 251 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 252 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3TL A 201 DBREF 1B11 A 4 116 UNP P16088 POL_FIVPE 42 154 SEQRES 1 A 113 VAL GLY THR THR THR THR LEU GLU LYS ARG PRO GLU ILE SEQRES 2 A 113 LEU ILE PHE VAL ASN GLY TYR PRO ILE LYS PHE LEU LEU SEQRES 3 A 113 ASP THR GLY ALA ASP ILE THR ILE LEU ASN ARG ARG ASP SEQRES 4 A 113 PHE GLN VAL LYS ASN SER ILE GLU ASN GLY ARG GLN ASN SEQRES 5 A 113 MET ILE GLY VAL GLY GLY GLY LYS ARG GLY THR ASN TYR SEQRES 6 A 113 ILE ASN VAL HIS LEU GLU ILE ARG ASP GLU ASN TYR LYS SEQRES 7 A 113 THR GLN CYS ILE PHE GLY ASN VAL CYS VAL LEU GLU ASP SEQRES 8 A 113 ASN SER LEU ILE GLN PRO LEU LEU GLY ARG ASP ASN MET SEQRES 9 A 113 ILE LYS PHE ASN ILE ARG LEU VAL MET HET SO4 A 251 5 HET SO4 A 252 5 HET 3TL A 201 33 HETNAM SO4 SULFATE ION HETNAM 3TL BENZYL [(1S,4S,7S,8R,9R,10S,13S,16S)-7,10-DIBENZYL-8,9- HETNAM 2 3TL DIHYDROXY-1,16-DIMETHYL-4,13-BIS(1-METHYLETHYL)-2,5, HETNAM 3 3TL 12,15,18-PENTAOXO-20-PHENYL-19-OXA-3,6,11,14,17- HETNAM 4 3TL PENTAAZAICOS-1-YL]CARBAMATE HETSYN 3TL TL-3, C2 SYMMETRIC INHIBITOR FORMUL 2 SO4 2(O4 S 2-) FORMUL 4 3TL C50 H64 N6 O10 FORMUL 5 HOH *60(H2 O) HELIX 1 1 ARG A 40 ASP A 42 5 3 HELIX 2 2 ARG A 104 PHE A 110 1 7 SHEET 1 A 4 TYR A 23 LEU A 28 0 SHEET 2 A 4 GLU A 15 VAL A 20 -1 N VAL A 20 O TYR A 23 SHEET 3 A 4 VAL A 71 ILE A 75 -1 N GLU A 74 O PHE A 19 SHEET 4 A 4 CYS A 84 GLY A 87 -1 N GLY A 87 O VAL A 71 SHEET 1 B 4 ILE A 37 ASN A 39 0 SHEET 2 B 4 VAL A 89 LEU A 92 1 N CYS A 90 O LEU A 38 SHEET 3 B 4 GLY A 62 TYR A 68 -1 N TYR A 68 O VAL A 89 SHEET 4 B 4 ARG A 53 ILE A 57 -1 N MET A 56 O LYS A 63 LINK C2 3TL A 201 C2 3TL A 201 1555 5555 1.54 SITE 1 AC1 6 LYS A 12 ARG A 13 TYR A 23 LYS A 46 SITE 2 AC1 6 HOH A 327 HOH A 345 SITE 1 AC2 2 ARG A 53 HIS A 72 SITE 1 AC3 12 PRO A 24 ASP A 30 GLY A 32 ALA A 33 SITE 2 AC3 12 ASP A 34 ASN A 55 MET A 56 ILE A 57 SITE 3 AC3 12 GLY A 58 VAL A 59 LEU A 101 HOH A 301 CRYST1 50.745 50.745 73.458 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019706 0.011377 0.000000 0.00000 SCALE2 0.000000 0.022755 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013613 0.00000